People are lucky if they go to one great hospital for AIDS treatment. Others go to thirty-four.

Clinical Trials Units

LOCATION AND CONTACT INFORMATION


Please contact your local site for information about HIV/AIDS clinical research being conducted in your area. Select from the list of states or click on the states in red for a complete listing of locations and contact information (address,telephone number, and click on link to local website). Main AIDS Clinial Trials Units (ACTUs) are designated with "*".

For General Questions about the ACTG please complete the Feedback Form.

AIDS CLINICAL TRIALS UNITS (ACTU)


The ACTG is a cooperative group consisting of 34 AIDS Clinical Trials Units (ACTUs) in the United States and a collaborative network of International Clinical Trials Units. Each ACTU is directed by a Principal Investigator with a Study Coordinator.

AIDS Clinical Trials Units (ACTUs) Principal Investigator
Study Coordinator
Bellevue Hospital (NYU) - 0401Judy Aberg, Principal Investigator
Maura Laverty, Study Coordinator
Beth Israel Medical Center - 2851Donna Mildvan, Principal Investigator
Ann Marshak, Study Coordinator
Case Western Reserve University - 2501Michael Lederman, Principal Investigator
Jane Baum, Study Coordinator
Columbia University - 7802Scott Hammer, Principal Investigator
Mykyelle Crawford, Study Coordinator
Duke University Medical Center - 1601John A. Bartlett, Principal Investigator
Eang King, Study Coordinator
Harvard University - 0101
(Massachusetts General Hospital)
Daniel Kuritzkes, Principal Investigator
Teri Flynn, Study Coordinator
Indiana University Hospital - 2601Mitchell Goldman, Principal Investigator
Beth Zwickl, Study Coordinator
Johns Hopkins University - 0201Charles Flexner, Principal Investigator
Ilene Wiggins, Study Coordinator
The Miriam Hospital - 2951Timothy Flanigan, Principal Investigator
Pamela Poethke, Study Coordinator
Northwestern University - 2701Robert Murphy, Principal Investigator
Baiba Berzins, Study Coordinator
Ohio State University - 2301Susan Koletar, Principal Investigator
Todd Lusch, Study Coordinator
San Francisco General Hospital - 0801Diane Havlir, Principal Investigator
Michele Downing, Study Coordinator
Stanford University - 0501Andrew Zolopa, Principal Investigator
Debbie Slamowitz, Study Coordinator
University of Alabama at Birmingham - 5801Michael Saag, Principal Investigator
Karen Savage, Study Coordinator
University of California, Davis Medical Center - 3851Richard Pollard, Principal Investigator
Gary Collins Study Coordinator
University of California, Los Angeles
School of Medicine - 0601
Judith Currier, Principal Investigator
Sofia Solis, Study Coordinator
University of California, San Diego - 0701Constance Benson, Principal Investigator
Jill Kunkel, Study Coordinator
University of Cincinnati - 2401Judith Feinberg, Principal Investigator
Tammy Powell, Study Coordinator
University of Colorado Health
Sciences Center - 6101
Thomas Campbell, Principal Investigator
M. Graham Ray, Study Coordinator
University of Hawaii - 5201Cecilia Shikuma, Principal Investigator
Debra Ogata-Arakaki, Study Coordinator
University of Maryland - 4651Robert Redfield, Principal Investigator
Sandy Zaremba, Study Coordinator
University of Miami - 0901Margaret Fischl, Principal Investigator
Leslie Thompson, Study Coordinator
University of Minnesota - 1501Henry Balfour, Jr., Principal Investigator
Christine Fietzer, Study Coordinator
University of North Carolina - 3201Joseph Eron, Principal Investigator
Cheryl Marcus, Study Coordinator
University of Pennsylvania - 6201Pablo Tebas, Principal Investigator
Joseph Quinn, Study Coordinator
University of Pittsburgh - 1001John Mellors, Principal Investigator
Christine Tripoli, Study Coordinator
University of Puerto Rico - 5401Jorge Santana, Principal Investigator
Sylvia Davila, Study Coordinator
University of Rochester Medical
Center - 1101
Richard Reichman, Principal Investigator
Carol Greisberger, Study Coordinator
University of Southern California - 1201Fred Sattler, Principal Investigator
Luis Mendez, Study Coordinator
University of Texas, Galveston - 6301William O'Brien, Principal Investigator
Gerianne Casey, Study Coordinator
University of Texas, Southwestern
Medical Center - 3751
Philip Keiser, Principal Investigator
Chip Lohner, Study Coordinator
University of Washington (Seattle) - 1401Ann Collier, Principal Investigator
Jeanne Conley, Study Coordinator
Vanderbilt University - 3651David Haas, Principal Investigator
Janet Nicotera, Study Coordinator
Washington University (St. Louis) - 2101David Clifford, Principal Investigator
Michael Klebert, Study Coordinator

INTERNATIONAL CLINICAL TRIALS UNITS


The ACTG has identified a network of internationally based investigators at sites in Africa, Asia, Latin America and the Caribbean with whom we are developing a collaborative research effort. Each international site is linked with a partner U.S. site.

International Clinical Trials Units Principal Investigator
Study Coordinator
University of Witwatersrand, Johannesburg, South Africa (11101) Ian M. Sanne, Principal Investigator
Pauline S. Vunandlala, Study Coordinator
University of KwaZulu-Natal, Durban, South Africa (11201) Umesh Gangharam Lalloo, Principal Investigator
Sandy Pillay, Study Coordinator
Asociacion Civil Impacta Salud y Educacion, Lima, Peru (11301) Jorge L. Sanchez, Principal Investigator
Juan V. Guanira, Study Coordinator
Les Centres GHESKIO, Port-au-Prince, Haiti (11401) Jean William Pape, Principal Investigator
Estere Michel, Study Coordinator
Chiang Mai University, Chiang Mai, Thailand (11501) Khuanchai Supparatpinyo, Principal Investigator
Daralak Tavornprasit, Study Coordinator
National AIDS Research Institute, Pune, India (11601) Srikanth Prasad Tripathy, Principal Investigator
Anjali Joglekar, Study Coordinator
YRG Centre for AIDS Research & Education, Chennai, India (11701) Nagalingeshwaran (Kumar) Kumarasamy, Principal Investigator
Aylur Kailasom Srikrishnan, Study Coordinator
University of Zimbabwe, Harare, Zimbabwe (11801) James Gita Hakim, Principal Investigator
Elizabeth Dangaiso, Study Coordinator
University of Malawi, Blantyre, Malawi (11901) Johnstone Kumwenda, Principal Investigator
Stacey Hurst, Study Coordinator
Lilongwe Central Hospital Campus, Lilongwe, Malawi (12001) Mina Christine Hosseinipour, Principal Investigator
Cecilia Kanyama, Study Coordinator
Oswaldo Cruz Foundation, Rio de Janeiro, Brazil (12101) Beatriz Grinsztejnr, Principal Investigator
Sandra Wagner Cardoso, Study Coordinator
Hospital Nossa Schora da Conceicao, Porto Alegre, Brazil (12201) Breno Riegel Santos, Principal Investigator
Rita de Cassia Alves Lira, Study Coordinator
Chris Hani Baragwaneth Hospital, Johannesburg, Soweto, South Africa (12301) James Alasdair McIntyre, Principal Investigator
Rebiditshe Leketi, Study Coordinator
Joint Clinical Research Centre, Kampala, Uganda (12401) Peter Mugyenyi, Principal Investigator
Sandra Rwambuya, Study Coordinator
Walter Reed Project, Kericho, Kenya (12501) Fred Sawe, Principal Investigator
Hellen Ngeno, Study Coordinator
MOI University Faculty of Health Sciences, Eldoret, Kenya (12601) Abraham Siika, Principal Investigator
Kipruto Kirwa, Study Coordinator
Botswana Harvard School of Public Health AIDS Unit, Garborone, Botswana (12701) Shahin Lockman, Principal Investigator
Aida Asmelash, Study Coordinator
Centre for Infectious Disease Research Zambia, Lusaka, Zambia (12801) Elizabeth Stringer, Principal Investigator
Allison Zerbe, Study Coordinator
Kilimanjaro Christian Medical Center, Kilimanjaro, Tanzania (12901) John Shao, Principal Investigator
Juma Nyakina, Study Coordinator
MA RI NY GA AL MD PA NC TN OH IN MO IL IA FL NE HI PR TX MN CO WA CA
AIDS Clinical Trials Group | About the ACTG | News and Announcements | Science Mission | Community Involvement | Clinical Trials | Resources | © 2003-5 ACTG